Form 8-K - Current report:
SEC Accession No. 0001628280-25-029019
Filing Date
2025-06-03
Accepted
2025-06-03 16:05:12
Documents
14
Period of Report
2025-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jush-20250603.htm   iXBRL 8-K 43151
2 EX-99.1 ex991-pressreleaseofjushih.htm EX-99.1 23747
6 GRAPHIC image_0a.jpg GRAPHIC 17127
  Complete submission text file 0001628280-25-029019.txt   206780

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jush-20250603.xsd EX-101.SCH 1770
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jush-20250603_lab.xml EX-101.LAB 20974
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jush-20250603_pre.xml EX-101.PRE 12037
16 EXTRACTED XBRL INSTANCE DOCUMENT jush-20250603_htm.xml XML 2630
Mailing Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431
Business Address 301 YAMATO ROAD SUITE 3250 BOCA RATON FL 33431 5616179100
Jushi Holdings Inc. (Filer) CIK: 0001909747 (see all company filings)

EIN.: 981547061 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56468 | Film No.: 251019325
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)